Kyoto University researchers have regenerated neural stem cells in an adult mouse and improved its cognitive function through its method, dubbed "iPaD."
The test results were equivalent to turning a 60-year-old-human's neural stem cells into those of a teenager.
However, there are challenges in applying the procedure to humans because the mouse’s genetic engineering involved using a virus to inject the genes into the brain.
The research team’s leader, visiting professor Ryoichiro Kageyama, said they would continue to see if the procedure can be applied to humans.
The team will now test its iPaD method on marmosets to determine if its applicability to primates.
The ability to multiply embryonic neural stem cells to increase the number of nerve cells weakens with age. That, in turn, results in reduced cognitive function.
The iPaD method maximizes the activation of the neural stem cells by combining the infant mice’s most active genes with a restraining function of the adult mice’s most active genes.
The engineered neural stem cells in an adult mouse became more active with the neural stem cells continuing to multiply for about three months.
|Consequently, the adult mouse improved its cognitive function with the increase in neural stem cell multiplication.


Costco Q3 Fiscal 2026 Earnings Beat Expectations as Sales and E-Commerce Surge
Asian Stocks Rally as AI Boom and Iran Ceasefire Progress Lift Market Sentiment
Oil Prices Set for Sharp Weekly Losses as U.S.-Iran Ceasefire Hopes Ease Supply Concerns
South Korea Central Bank Holds Interest Rates Steady Amid Inflation Concerns
S&P 500 Hits Record High as Tech Rally Slows Amid Iran Peace Uncertainty
Dell Raises 2027 Revenue Forecast as AI Server Demand Drives Record Quarterly Results
US Quantum Stocks Surge After $2 Billion Government Investment
Gold Prices Hold Near Record Levels as Inflation Concerns Offset Middle East Ceasefire Hopes
Canada and Germany Advance Major LNG Supply Partnership
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Trump Administration Releases New UFO Files and Apollo Mission Records
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Snowflake Stock Soars 30% After Q1 Earnings Beat and Major AWS AI Partnership
CTOC Goes Live on Bitget Wallet Trading, Expanding Global Access to AI-Powered Healthcare Data Ecosystem
NASA's Artemis II Mission: First Crewed Lunar Journey Since Apollo
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Tabletop particle accelerator could transform medicine and materials science 



